about
Epigenomics of leukemia: from mechanisms to therapeutic applicationsAn integrative genomic and epigenomic approach for the study of transcriptional regulationEpigenetic silencing of the human nucleotide excision repair gene, hHR23B, in interleukin-6-responsive multiple myeloma KAS-6/1 cells.Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2'-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis.The rise and fall of genomic methylation in cancer.The role of DNA hypermethylation in the pathogenesis and prognosis of acute lymphoblastic leukemia.Methylation of INK4 and CIP/KIP families of cyclin-dependent kinase inhibitor in chronic lymphocytic leukaemia in Chinese patientsPalliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An in vitro and clinical study.Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia.Models of granulocyte DNA structure are highly predictive of myelodysplastic syndromeDemethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy.All-trans retinoic acid enhances the effect of 5-aza-2'-deoxycytidine on p16INK4a demethylation, and the two drugs synergistically activate retinoic acid receptor β gene expression in the human erythroleukemia K562 cell lineAndrogen receptor CpG island methylation status in human leukemia cancer cells.Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours.A survey of splice variants of the human hypoxanthine phosphoribosyl transferase and DNA polymerase beta genes: products of alternative or aberrant splicing?Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms.DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma.Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms.
P2860
Q26823403-D07EC901-7B2A-40F2-89C6-A09C04CE1AABQ33325492-A7B02631-9EA1-4BE6-BF9D-5874161BF150Q34369130-9D320EF4-AA0F-43CD-A835-063E7827EC8CQ34450695-B060EEFC-BA60-42BD-BDBA-D50E5A425941Q35589077-22CDFD19-EE2F-407D-AC12-DA02615CAB98Q35635538-ECD71348-4020-44D8-BF20-42AC16D379B6Q35770277-9DBCC18A-C2DE-4458-B6FE-43979DD2B16DQ35948096-FCC10CB2-42C3-403F-B886-54452DAC89B4Q37324449-2BBC1084-8B59-4EC1-BD69-056F0D63541DQ37415850-AA5EA995-2CA7-4D82-B41D-01589D327C1AQ38081950-5755541A-69AB-4D44-BFEF-30AF80890D80Q38981800-B2C7732F-A066-463C-84BC-7C601E284F76Q39880790-98C83BBD-F00E-42B8-9DF7-3D6464710218Q40236553-1E4D2BBC-F5CC-4642-A932-8958A0F5356DQ40448817-1624BEBD-6D48-47D3-B8F6-D8A0AC247659Q40480300-919667A9-A3D8-4D27-B6BA-AF037B9500F2Q41550137-EC8BEBD9-2504-42D5-89E2-F33FF51D6636Q46110570-96D5B072-F838-4D89-94D4-02A2C5AFB7D7Q47129670-9565F382-FB39-4AAD-95A6-244E94D3EECDQ53817619-B0614C0A-564B-4275-9C70-783C7D30CCBC
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
DNA methylation changes in leukaemia.
@ast
DNA methylation changes in leukaemia.
@en
DNA methylation changes in leukaemia.
@nl
type
label
DNA methylation changes in leukaemia.
@ast
DNA methylation changes in leukaemia.
@en
DNA methylation changes in leukaemia.
@nl
prefLabel
DNA methylation changes in leukaemia.
@ast
DNA methylation changes in leukaemia.
@en
DNA methylation changes in leukaemia.
@nl
P1476
DNA methylation changes in leukaemia.
@en
P2093
John R Melki
P304
P356
10.1016/S1044-579X(02)00055-X
P50
P577
2002-10-01T00:00:00Z